CollPlant Biotechnologies Ltd. ( CLGN) - Key Metrics
CLGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $0.05 | -$2.25 | -$2.22 | -$2.22 |
| 2025Q4 | $0.05 | -$2.50 | -$2.51 | -$2.52 |
| 2025Q3 | $0.06 | -$2.74 | -$2.26 | -$2.26 |
| 2025Q2 | $0.15 | -$2.83 | -$2.06 | -$2.06 |
| 2025Q1 | $1.79 | -$1.27 | -$1.02 | -$1.03 |
CLGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | -0.58 |
| 2025Q4 | 0% | -1.40 |
| 2025Q3 | 0% | -2.49 |
| 2025Q2 | 0% | -1.21 |
| 2025Q1 | 0% | -4.96 |
CLGN
Price: $3.68
52 week price:
Earnings Per Share: -10.40 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 28000
Market Capitalization: 4.5 million